SCHEMBL5066069

SCHEMBL5066069

CC(=O)OCC(=O)OOc1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
CXCL8 P10145 1/20 0.39
ALDH1A1 P00352 6/20 0.39
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
NLRP3 Q96P20 1/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 3/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM4E B2RXH2 1/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
GAA P10253 1/20 0.37
TDP1 Q9NUW8 2/20 0.37
FKBP1A P62942 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3739813 0.81 ALDH1A1 (0.44) SMN1; SMN2CXCL8ALDH1A1HPGDHSD17B10
SCHEMBL27602026 0.80 KDM4E (0.44) SMN1; SMN2CXCL8ALDH1A1HPGDHSD17B10
SCHEMBL3976536 0.78 MAOB (0.41) SMN1; SMN2ALDH1A1KMT2AMAPTMEN1
SCHEMBL6257223 0.75 KDM4E (0.50) CXCL8KMT2AMEN1KDM4E
SCHEMBL30569631 0.72 KDM4E (0.54) SMN1; SMN2ALDH1A1HPGDKMT2ALMNA
SCHEMBL10527284 0.72 CXCL8 (0.49) SMN1; SMN2CXCL8ALDH1A1HPGDHSD17B10
SCHEMBL247351 0.70 PTGS2 (0.57) SMN1; SMN2CXCL8ALDH1A1HPGDHSD17B10
SCHEMBL2320160 0.69 ALDH1A1 (0.54) SMN1; SMN2CXCL8ALDH1A1HPGDKMT2A
SCHEMBL15197111 0.69 HPGD (0.55) SMN1; SMN2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL7365892 0.69 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 SMN1; SMN2 2982/4885CXCL8 676/4885ALDH1A1 2628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.